Main details

Issuer name
AS Bravo Pharmaceuticals
Registration code
14159974
ISIN code
EE3802139354
Name of instrument
BRAVO PHARMACEUTICALS AKTSIA täiendav 2
Name of instrument (in english)
BRAVO PHARMACEUTICALS AKTSIA additional 2
Instrument type
Equities
Event reference
PARIEE0000001489
Event type
Pari passu
Event status
Finished
Start date of processing
Feb 28, 2022
End date of processing
Mar 1, 2022
Entry in the Commercial Register
Feb 18, 2022
Record date
Feb 28, 2022
Relevant notice
Aktsionäride otsus 08.02.2022 suurendada kapitali 113 137 euro võrra 163 337€ / Increase of capital by 113 137 euro total capital after 163 337€
Linked event
48193
Date of meeting
Feb 8, 2022
Event ID
48194

Options

Option number
001
Option type
Distribution of securities to holders
Security movements
ISIN code
EE3802139354
Name
BRAVO PHARMACEUTICALS AKTSIA täiendav 2
Name in english
BRAVO PHARMACEUTICALS AKTSIA additional 2
Source total
113,137
Source total after
0
Transaction date
Mar 1, 2022
Last trading date
Feb 23, 2022
Security movements
ISIN code
EE3100139353
Name
BRAVO PHARMACEUTICALS AKTSIA
Name in english
SHS BRAVO PHARMACEUTICALS ORD
Source total
113,137
Source total after
0
Destination total
113,137
Destination total after
163,337
Transaction date
Mar 1, 2022
Given
1
For every
1
Nasdaq CSD Lithuania